Our data show that for growth melanoma cells not only depend on activators but also on inhibitors of MAPK signaling activity such as DUSP4. The melanoma‐specific genetic dependencies identified might be explored as novel specific therapeutic targets. Here, DUSP4 is linked to melanoma.